Janney Montgomery Scott
AGRX

Janney Montgomery Scott’s Agile Therapeutics AGRX Stock Holding History

Janney Montgomery Scott’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10
Closed -$4K – 2476
2022
Q1 		$4K Buy
10
+5
+100% +$3.19K ﹤0.01% 2227
2021
Q4 		$5K Buy
+5
New +$7.05K ﹤0.01% 2360
2020
Q1 		– Sell
-6
Closed -$30K – 2135
2019
Q4 		$30K Buy
+6
New +$21K ﹤0.01% 2044
2018
Q1 		– Sell
-20
Closed -$108K – 2029
2017
Q4 		$108K Buy
20
+2
+11% +$18.6K ﹤0.01% 1880
2017
Q3 		$158K Buy
18
+2
+13% +$15.4K ﹤0.01% 1747
2017
Q2 		$122K Buy
+16
New +$111K ﹤0.01% 1684

Other funds holding AGRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Janney Montgomery Scott's AGRX Position: Q2 2022 in Review

Janney Montgomery Scott sold out of Agile Therapeutics (AGRX) in Q2 2022, closing a stake of 10 shares — an estimated $4K sold.

Janney Montgomery Scott first reported a position in AGRX in Q2 2017 and held it in 6 quarters. The position peaked at $158K in Q3 2017. 19 funds tracked by Wall St. Rank hold AGRX as of Q2 2022.

  • Janney Montgomery Scott reported no remaining Agile Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Janney Montgomery Scott sold 10 Agile Therapeutics shares in Q2 2022, an estimated $4K.
  • Janney Montgomery Scott first reported a position in Agile Therapeutics in Q2 2017 and held it in 6 quarters.
  • Janney Montgomery Scott's Agile Therapeutics position peaked at $158K in Q3 2017.
  • 19 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2022.

Based on Janney Montgomery Scott's 13F filing for Q2 2022, filed 3 Aug 2022.